Global Drugs of Abuse Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Drugs of Abuse Testing Market is presumed to reach the market size of nearly USD 23.15 Billion by 2032 from USD 6.99 Billion in 2023 with a CAGR of 14.23% under the study period 2024 - 2032.

Drugs of abuse testing refers to the analysis of biological samples to identify the existence of illicit drugs or prescription medications used for non-medical purposes. These tests are conducted to monitor drug use, ensure compliance with drug rehabilitation programs, and identify individuals under the influence of drugs. Various methods, such as urine, saliva, blood, and hair testing, are employed to screen for drugs like cannabis, cocaine, opioids, amphetamines, and benzodiazepines. This testing is essential in law enforcement, workplace safety, healthcare, and addiction treatment settings to prevent drug abuse, support rehabilitation efforts, and maintain public health and safety.

MARKET DYNAMICS

The rising prevalence of substance abuse globally is a major driving force behind the increasing demand for drug abuse testing. Governments and regulatory bodies across various regions are implementing stringent laws and regulations to combat drug abuse, thereby boosting the adoption of drug testing procedures in workplaces, law enforcement agencies, and rehabilitation centers. Moreover, the growing awareness regarding the detrimental effects of drug abuse on public health and safety is encouraging employers, educational institutions, and healthcare facilities to implement routine drug testing programs. Additionally, advancements in drug testing technologies, including the development of rapid testing kits, point-of-care devices, and laboratory-based analytical techniques, enhance the efficiency, accuracy, and reliability of drug abuse testing, further driving market growth. Furthermore, expanding drug testing services offered by diagnostic laboratories, drug testing companies, and healthcare providers to cater to the increasing demand contributes to market expansion.

Moreover, the emergence of new psychoactive substances and the ongoing opioid epidemic are fuelling the need for comprehensive and multi-panel drug testing solutions, driving innovation in the market. Additionally, the increasing adoption of drug testing in pre-employment screening, sports organizations, and transportation sectors to ensure safety and compliance with regulations is boosting market demand. Furthermore, the growing focus on workplace wellness programs and employee health initiatives is driving the integration of drug testing as part of comprehensive health assessments, further propelling market growth. However, advancements in drug detection technologies and regulatory changes may challenge the drug abuse testing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of drugs of abuse testing. The growth and trends of drugs of abuse testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the drugs of abuse testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers)
Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices)
Consumables (Fluid Collection Devices, Others)

By Sample Type

Saliva
Breath
Urine
Blood
Hair & Sweat

By Testing Type

Pain Management Testing
Criminal Justice Testing
Workplace Screening

By End-User

Hospitals
Diagnostics Laboratories
On-The-Spot Testing
Forensic Laboratories

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drugs of Abuse Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drugs of Abuse Testing market include Laboratory Corporation of America Holdings, Danaher Corporation, Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Dragerwerk AG & Co. KGaA, Shimadzu Corporation, CareHealth America Corp. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114183

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . DRUGS OF ABUSE TESTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Sample Type
- 3.7.3 Market Attractiveness Analysis By Testing Type
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Analyzers (Immunoassays Analyzers, Chromatographic Devices, Breath Analyzers) Historic and Forecast Sales by Regions
5.5 Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devices) Historic and Forecast Sales by Regions
5.6 Consumables (Fluid Collection Devices, Others) Historic and Forecast Sales by Regions

6 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY SAMPLE TYPE

6.1 Overview by Sample Type
6.2 Historical and Forecast Data
6.3 Analysis by Sample Type
6.4 Saliva Historic and Forecast Sales by Regions
6.5 Breath Historic and Forecast Sales by Regions
6.6 Urine Historic and Forecast Sales by Regions
6.7 Blood Historic and Forecast Sales by Regions
6.8 Hair & Sweat Historic and Forecast Sales by Regions

7 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY TESTING TYPE

7.1 Overview by Testing Type
7.2 Historical and Forecast Data
7.3 Analysis by Testing Type
7.4 Pain Management Testing Historic and Forecast Sales by Regions
7.5 Criminal Justice Testing Historic and Forecast Sales by Regions
7.6 Workplace Screening Historic and Forecast Sales by Regions

8 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Diagnostics Laboratories Historic and Forecast Sales by Regions
8.6 On-the-spot Testing Historic and Forecast Sales by Regions
8.7 Forensic Laboratories Historic and Forecast Sales by Regions

9 . GLOBAL DRUGS OF ABUSE TESTING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DRUGS OF ABUSE TESTING COMPANIES

10.1. Drugs Of Abuse Testing Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF DRUGS OF ABUSE TESTING INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Laboratory Corporation of America Holdings
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Danaher Corporation
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Abbott
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Thermo Fisher Scientific Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. F. Hoffmann-La Roche Ltd.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Siemens Healthineers
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Dragerwerk AG & Co. KGaA
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Shimadzu Corporation
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. CareHealth America Corp.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies